Abstract:Background: Assess the current and potential indications of photobiomodulation (PBM) therapy and their level of evidence in the prevention or treatment of side effects related to oncology treatments (radiation therapy, and to a minimal extent favored and hematopoietic stem cell transplants). And report on the recommended modalities (parameters and doses) of PBM therapy. Materials and methods: The Embase, Medline/PubMed, Cochrane, EBSCO, Scopus, and LILACS databases were systematically reviewed to include and analyze publications of clinical studies that evaluated PBM in the prevention or management side effects related to cancer treatments. The keywords used were "photobiomodulation"; "low level laser therapy"; "acute oral mucositis"; "acute dysphagia"; "acute radiation dermatitis"; "lymphedema"; "xerostomia"; "dysgeusia"; "hyposalivation"; "lockjaw"; "bone necrosis"; "osteoradionecrosis"; "radiation induced fibrosis"; "voice and speech alterations"; "palmar-plantar erythrodysesthesia"; "graft versus host disease"; "peripheral neuropathy"; "chemotherapy induced alopecia". Prospective studies were included, while retrospective cohorts and non-original articles were excluded from the analysis. Results: PBM in the red or infrared spectrum has been shown to be effective in randomized controlled trials in the prevention and management of certain complications related to radiotherapy, in particular acute mucositis, epitheliitis and upper limb lymphedema. The level of evidence associated with PBM was heterogeneous, but overall remained moderate. The main limitations were the diversity and the lack of precision of the treatment protocols which could compromise the efficiency and the reproducibility of the results of the PBM. For other effects related to chemo/radiation therapy (dysgeusia, osteonecrosis, peripheral neuropathy, alopecia, palmar-plantar erythrodysaesthesia) and haematopoietic stem cell transplantation (graft versus host disease), treatment with PBM suffers from a lack of studies or limited studies at the origin of a weakened level of proof. However, based on these results, it was possible to establish safe practice parameters and doses of PBM. Conclusion: Published data suggest that PBM could therefore be considered as supportive care in its own right for patients treated with radiation, chemotherapy, immunotherapy, hormone therapy or targeted therapies, whether in clinical practice or clinical trials. therapies. However, until solid data have been published on its long-term safety, the use of PBM should be considered with caution and within the recommended parameters and doses, particularly when practiced in areas of known or possible tumours. In this case, the patient should be informed of the theoretical benefits and risks of PBM in order to obtain informed consent before treatment.

The supportive use of photobiomodulation on salivary glands: a narrative review and meta-analysis

Photobiomodulation As Therapy For Hyposalivation And Xerostomia In Patients Undergoing Radiotherapy: A Narrative Review.

Photobiomodulation therapy on chemo- and radiotherapy induced oral conditions: an umbrella review

Underexplored Areas of Photobiomodulation in Oral Oncology: An Expert Analysis

Diagnosis, Prevention, and Treatment of Radiotherapy-Induced Xerostomia: A Review

Long Term Evaluation Of Salivary Glands After Photobiomodulation During Radiotherapy For Head And Neck Cancer.

Photobiomodulation Therapy In Patient With Sjogren ́S Syndrome: A Serie Of Cases.

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact

Evaluation of the Effect of Photobiomodulation on Radiation-Induced Xerostomia in Head and Neck Cancer Patients: A Randomized Clinical Trial

Effectiveness Of Photbiomodulation Therapy For Oral Mucositis Secondary To Antineoplasic Therapy: An Overview.

Photobiomodulation Therapy In The Control Of Radio-Induced Oral Mucositis: Observational Retrospective Case-Control Study.

Randomized Double-Blind Placebo-Controlled Study of Salivary Substitute with Enzymatic System for Xerostomia in Patients Irradiated in Head and Neck Region

Efficacy of photobiomodulation therapy combined with mobile health education in patients with head and neck cancer suffering from chronic xerostomia after radiotherapy: protocol for a three-arm, randomised, placebo-controlled, double-blinded study

Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia

Photobiomodulation and salivary glands: a systematic review

[Photobiomodulation in the prevention and the management of side effects of cancer treatments: Bases, results and perspectives]

Efficacy of Office-Based Salivary Ductal Steroid Irrigation for Managing Post-Irradiation Xerostomia in Head and Neck Cancer Patients: A Retrospective Study

Might photobiomodulation therapy interfere with the frequency of severe mucositis and oral candidiasis? A retrospective analysis in patients with head and neck carcinoma

Cancer treatment-related xerostomia: basics, therapeutics, and future perspectives

Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia

Assessing the Cost-Effectiveness of Photobiomodulation for Oral Mucositis Prevention and Treatment: A Systematic Review